Artizan Bio Taps Synlogic’s Paul Miller for Chief Scientific Officer

Xconomy Boston — 

Paul Miller has joined Artizan Biosciences as chief scientific officer, the same position he held at Synlogic (NASDAQ: SYBX). Miller’s experience also includes senior roles at AstraZeneca (NYSE: AZN) and Pfizer (NYSE: PFE). New Haven, CT-based Artizan Bio, a spinout of Yale University, is developing drugs that target the gut microbiome.